Envoy Medical, Inc. COCH
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2021-03-02
Envoy Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -9240.7% | -8558.2% | -5809.8% | -3673.4% | — |
| Net margin | -9857.3% | -9242.2% | -9469.0% | -6718.6% | — |
| FCF margin | -7626.6% | -8412.9% | -5457.0% | -3807.2% | — |
| Return on assets | -277.6% | -180.2% | -361.8% | -623.0% | -0.1% |
| Return on equity | 195.4% | 110.4% | 1684.8% | 44.0% | 0.6% |
| Current ratio | 0.54 | 1.18 | 1.02 | 0.65 | 0.32 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.